Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Marken Expands Kit-Building Operations in Singapore

Published: Friday, August 16, 2013
Last Updated: Friday, August 16, 2013
Bookmark and Share
Singapore joins Marken’s other facilities around the globe.

Marken has announced that they have expanded their kit-building operations into Singapore due to a growing demand from its clients. The facility is fully operational and began shipping for its first client earlier this year.

The kit-building unit in Singapore is managed by a dedicated trained staff and is supported by the GMP operators and QA personnel who operate the depot facility.

The depot / kit facility is also adjacent to Marken’s Singapore distribution hub, located near the Chiangi airport. Marken staff can therefore receive drug product and kit materials at the depot, assemble and store kits, store drug product and distribute all clinical materials to investigator sites throughout Asia.

The addition of the Singapore site is part of an ongoing global expansion plan within Marken. With kit-building locations already operational in Hamburg, and now Singapore, Marken is also evaluating an additional kit-building facility in either Miami or Brazil in the coming months.

Marken currently produces 15,000 kits per month and distributes more than 350,000 kits annually to investigator sites around the world. Ample capacity is currently available, and more capacity will be added as client demand develops.

Wes Wheeler, Marken’s Chief Executive Officer, said, “We are pleased to be able to offer this expanded service to our clients in the APAC region. Our ability to assemble kits in Singapore gives us a solid platform in Asia and again enhances our portfolio of services to clients in the region. We look forward to serving more global clients with our other facilities as we continue to grow, both in the Asia region and around the world.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Marken Opens New Chicago Location
The new location will work in concert with its clients and investigator sites to collect and ship drug products, clinical trial materials and biological samples.
Thursday, November 17, 2016
UPS to Acquire Marken
Acquisition to complement UPS healthcare logistics solutions transaction highlights.
Thursday, November 10, 2016
Marken Opens New Location in Brisbane, Australia
The opening of the new office is a result of rapid growth in the region and will support Marken’s existing office in Sydney.
Thursday, October 27, 2016
Marken Announces New Operations Center in Zurich
New GDP-compliant facility expanded and relocated to serve its pharma clients in Switzerland.
Friday, August 19, 2016
Marken Announces Completion of New Moscow Depot
New location will serve a growing number of new clinical trials in Russia.
Tuesday, December 15, 2015
Marken Offers Exclusive GPS Technology for Shipments
The advanced tracking device delivers real time monitoring for a variety of conditions.
Thursday, August 20, 2015
Marken Opens New Philadelphia Hub
Distribution of clinical trial supplies within all temperature ranges.
Saturday, May 16, 2015
Marken Announces Moscow Depot
Marken’s global depot network expands to seven.
Thursday, October 03, 2013
Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!